KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Finished Goods (2016 - 2022)

Historic Finished Goods for Bio-Rad Laboratories (BIO) over the last 14 years, with Q2 2022 value amounting to $309.9 million.

  • Bio-Rad Laboratories' Finished Goods fell 618.16% to $309.9 million in Q2 2022 from the same period last year, while for Jun 2022 it was $309.9 million, marking a year-over-year decrease of 618.16%. This contributed to the annual value of $312.6 million for FY2021, which is 896.71% down from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Finished Goods of $309.9 million as of Q2 2022, which was down 618.16% from $306.0 million recorded in Q1 2022.
  • Bio-Rad Laboratories' 5-year Finished Goods high stood at $354.1 million for Q1 2018, and its period low was $298.3 million during Q4 2019.
  • Over the past 5 years, Bio-Rad Laboratories' median Finished Goods value was $331.6 million (recorded in 2018), while the average stood at $327.5 million.
  • Its Finished Goods has fluctuated over the past 5 years, first tumbled by 981.09% in 2019, then surged by 1512.04% in 2020.
  • Bio-Rad Laboratories' Finished Goods (Quarter) stood at $330.8 million in 2018, then decreased by 9.81% to $298.3 million in 2019, then rose by 15.12% to $343.4 million in 2020, then decreased by 8.97% to $312.6 million in 2021, then decreased by 0.88% to $309.9 million in 2022.
  • Its Finished Goods stands at $309.9 million for Q2 2022, versus $306.0 million for Q1 2022 and $312.6 million for Q4 2021.